Morning Industry Symposium:
Identifying the right patients for chemotherapy in ER+ HER2- breast cancer

Supported by Genomic Health

Friday, September 6, 2019
06:45-08:00
Hall B

06:45-08:00 Morning Industry Symposium:
Identifying the right patients for chemotherapy in ER+ HER2- breast cancer
Supported by Genomic Health
Chairperson Christy A. Russell, USA
07:00-07:30 Treatment decision-making for young patients in light of new evidence from TAILORx
Tiffany Traina, USA
07:30-08:00 Should all women with breast cancer and positive lymph nodes receive chemotherapy?
Christy A. Russell, USA